1 |
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia.
57
5
|
Noetzli L...Di Paola J
|
25807284 |
2015 |
2 |
Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.
57
5
|
Zhang MY...Shimamura A
|
25581430 |
2015 |
3 |
GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis.
5
|
Megy K...Freson K
|
34355501 |
2021 |
4 |
Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: a phase I, "windowofopportunity" study.
62
|
Moreno V...Vogelbaum MA
|
36455228 |
2022 |
5 |
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma.
62
|
Strati P...Budde LE
|
35861370 |
2022 |
6 |
Brainstem auditory pathway maturation in term neonates with congenital cytomegalovirus infection: a cohort study.
62
|
Kassis I...Meir M
|
36207473 |
2022 |
7 |
Clinical characteristics and maternal perinatal outcome in women with a confirmed diagnosis of COVID-19 in a hospital in Peru. Retrospective cohort study
62
|
Estrada-Chiroque LM...Amau-Chiroque JM
|
35503299 |
2022 |
8 |
Blockade of alpha2-adrenergic receptors in the caudal raphe region enhances the renal sympathetic nerve activity response to acute intermittent hypercapnia in rats.
62
|
Madirazza K...Dogas Z
|
35043650 |
2022 |
9 |
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies.
62
|
Ho J...Tan DSP
|
35432603 |
2022 |
10 |
Gemcitabine, carboplatin and veliparib in multiple relapsed/refractory germ cell tumours: The GCT-SK-004 phase II trial.
62
|
Mego M...Mardiak J
|
34052929 |
2021 |
11 |
A multicenter phase II study of TAS-114 in combination with S-1 in patients with pretreated advanced gastric cancer (EPOC1604).
62
|
Kawazoe A...Shitara K
|
32700159 |
2021 |
12 |
Sarcoidosis beyond pulmonary involvement: A case series of unusual presentations.
62
|
Medhat BM...Morad MA
|
34471595 |
2021 |
13 |
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial.
62
|
Silverberg JI...Rojo R
|
32492087 |
2020 |
14 |
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
62
|
Busani S...Girardis M
|
32807241 |
2020 |
15 |
Immature platelet fraction: A useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery.
62
|
Jeon K...Lee YK
|
32049816 |
2020 |
16 |
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
62
|
Mirza MR...AVANOVA investigators
|
31474354 |
2019 |
17 |
Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants.
62
|
Pollak U
|
31313454 |
2019 |
18 |
Predisposition to childhood acute lymphoblastic leukemia caused by a constitutional translocation disrupting ETV6.
62
|
Jarviaho T...Nordgren A
|
31519648 |
2019 |
19 |
Hemophagocytosis and Histoplasma-like fungal infection in 32 cats.
62
|
Schaefer DMW...Royal AB
|
31175684 |
2019 |
20 |
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254).
62
|
Chan JK...Gershenson DM
|
29921512 |
2018 |
21 |
Phrenic long-term depression evoked by intermittent hypercapnia is modulated by serotonergic and adrenergic receptors in raphe nuclei.
62
|
Stipica Safic I...Valic M
|
29617215 |
2018 |
22 |
Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support in pediatric patients: review of the literature and alternative anticoagulants.
62
|
Pollak U
|
29788841 |
2018 |
23 |
Germline ETV6 mutations and predisposition to hematological malignancies.
62
|
Feurstein S...Godley LA
|
28555414 |
2017 |
24 |
Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma-not otherwise specified.
62
|
Qi F...Shi Y
|
27858107 |
2017 |
25 |
Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia.
62
|
Ishizawa K...Tobinai K
|
28122892 |
2017 |
26 |
Thrombotic thrombocytopenic purpura in the course of systemic lupus erythematosus in a 15-year-old girl.
62
|
Szymanik-Grzelak H...Panczyk-Tomaszewska M
|
29472821 |
2017 |
27 |
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia.
62
|
Moreno C...Montserrat E
|
25596264 |
2015 |
28 |
A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338.
62
|
Roy V...Perez EA
|
22868240 |
2013 |
29 |
A retrospective study of chemotherapy with cisplatin plus gemcitabine after the failure of gemcitabine monotherapy for biliary tract cancer.
62
|
Kameda R...Ohkawa S
|
23619988 |
2013 |
30 |
Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial.
62
|
Zinzani PL...Coiffier B
|
23088650 |
2012 |
31 |
Referrals for suspected hematologic malignancy: a survey of primary care physicians.
62
|
Abel GA...Richardson LC
|
22473854 |
2012 |
32 |
[Analysis on the diagnosis and treatment of a cluster of cases infected by new bunyavirus].
62
|
Tang XY...Xu BL
|
22490190 |
2012 |
33 |
[Laboratory investigations in acute olanzapine poisonings].
62
|
Ciszowski K...Jawien W
|
22010428 |
2011 |
34 |
An outbreak of dengue fever in St. Croix (US Virgin Islands), 2005.
62
|
Mohammed H...Beatty ME
|
21060852 |
2010 |
35 |
Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
62
|
Choong NW...Cohen EE
|
19649772 |
2010 |
36 |
Emergency department awareness of heparin-induced thrombocytopenia: how frequently is risk assessment documented in patients with thrombosis?
62
|
Levine RL...Hursting MJ
|
20522721 |
2010 |
37 |
Acute renal failure in a patient with antiphospholipid syndrome and immune thrombocytopenic purpura treated with eltrombopag.
62
|
Sperati CJ...Streiff MB
|
20652968 |
2010 |
38 |
Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry.
62
|
Tamary H...Alter BP
|
20435624 |
2010 |
39 |
Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience.
62
|
Li J...Saif MW
|
20095915 |
2010 |
40 |
A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer.
62
|
Sharma A...Rath G
|
19575200 |
2010 |
41 |
Triweekly oxaliplatin plus oral capecitabine as first-line chemotherapy in elderly patients with advanced gastric cancer.
62
|
Dong N...Wang M
|
19581793 |
2009 |
42 |
Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer.
62
|
Lee GW...Kang JH
|
19151975 |
2009 |
43 |
Thrombocytopenia, an important interfering factor of antiviral therapy and hepatocellular carcinoma treatment for chronic liver diseases.
62
|
Kawaguchi T...Sata M
|
20103996 |
2009 |
44 |
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.
62
|
Olsen EA...Duvic M
|
17577020 |
2007 |
45 |
[Treatment with natural interferon (alfaferone) in clinical practice--our experience].
62
|
Dybowska D...Halota W
|
17702434 |
2007 |
46 |
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors.
62
|
Ryan DP...Eder JP
|
17036355 |
2006 |
47 |
Human granulocytic anaplasmosis in Austria: epidemiological, clinical, and laboratory findings in five consecutive patients from Tyrol, Austria.
62
|
Walder G...Wurzner R
|
16531117 |
2006 |
48 |
Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study.
62
|
Hotte SJ...Hirte HW
|
16284058 |
2006 |
49 |
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer.
62
|
Chan S...Moore L
|
15955899 |
2005 |
50 |
Gemcitabine/capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
62
|
Andres R...Tres A
|
16001994 |
2005 |